Free Trial

Compagnie Lombard Odier SCmA Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background
Remove Ads

Compagnie Lombard Odier SCmA lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 46.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,775 shares of the medical equipment provider's stock after acquiring an additional 1,192 shares during the quarter. Compagnie Lombard Odier SCmA's holdings in Intuitive Surgical were worth $1,970,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at approximately $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Erste Group Bank upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Tuesday, November 19th. Piper Sandler reissued an "overweight" rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. UBS Group lifted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Citigroup upped their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Finally, Evercore ISI lifted their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $613.10.

Remove Ads

Read Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Stock Performance

ISRG stock traded up $4.16 during trading on Monday, reaching $595.55. The company had a trading volume of 1,188,781 shares, compared to its average volume of 1,979,754. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The company has a market cap of $212.12 billion, a price-to-earnings ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. The firm has a 50-day simple moving average of $559.48 and a 200-day simple moving average of $520.19.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 6,348 shares of company stock worth $3,587,582. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last

NVIDIA is falling closer to the $100 mark—could it drop even further? Analysts predict up to 50% upside; is this a buying opportunity or a warning sign?

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
3 AI Stocks to Watch After NVIDIA’s Dip

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads